Research Programs


Human papillomavirus (HPV)-related oropharyngeal cancer incidence and trends in India


Understanding the natural history of oral HPV infection: an Indian perspective


Biomarkers of oral cancer risk prediction


Aetiology of human papillomavirus infections in head and neck cancer


Molecular HPV tests to establish endpoints for primary prevention of cervical cancer


Correlates of long lasting cell-mediated immune memory response to HPV vaccination

Current Research Grants

  • 2025 2020

    Accurate and satisfactory analysis of all high risk HPV types and some of the low risks including HPV 6 and 11 antibody titers for the 2-versus 3 dose HPV vaccination clinical trial in India- Follow-up study
    International Agency for Research on Cancer [IARC]- WHO

  • 2024 2019

    Human papillomavirus (HPV)-related oropharyngeal cancer burdenand the natural history of oral HPV infections: an Indianperspective.
    Wellcome Trust (UK) India Alliance program by the Department of Biotechnology [DBT]

  • 2023 2018

    Biomarkers of oral cancer risk prediction
    Department of Biotechnology [DBT]

  • 2022 2019

    HPV genotyping for efficacy testing of generic qHPV vaccine development: Serum Institute of India study
    Serum Institute of India


Rajiv Gandhi Centre for Biotechnology (RGCB),
Thycaud Post, Poojappura,
Thiruvananthapuram - 695 014, Kerala, India
+91-471-2529400 | 2347975 | 2348753

My Gov Prime Ministers National Relife Fund India Gov Make In India Make In India Data gov in

Last Updated on: July 12, 2024
CERT-In Certified Website